Affinia Therapeutics
Series CAffinia Therapeutics is a privately held company based in United States, founded in 2019. The latest disclosed round is Series C ($40m), dated Sep 16, 2025. Institutional investors on record include Google Ventures, NEA.
United States · EST 2019
What is Affinia Therapeutics?
Affinia Therapeutics is a privately held company based in United States, founded in 2019. The latest disclosed round is Series C ($40m), dated Sep 16, 2025. Institutional investors on record include Google Ventures, NEA. Develops Adeno-associated viruses(AAV) for gene therapy. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.
Which funds backed Affinia Therapeutics?
Who invested in Affinia Therapeutics?
Funds on the dated round table. Open a name to read the fund card.
| Investor | Round | Amount | Date |
|---|---|---|---|
| Google Ventures | Series C | $40m | Sep 16, 2025 |
| NEA | Series C | $40m | Sep 16, 2025 |
What do founders ask about Affinia Therapeutics?
What is Affinia Therapeutics?
Affinia Therapeutics is a privately held company based in United States, founded in 2019. The latest disclosed round is Series C ($40m), dated Sep 16, 2025. Institutional investors on record include Google Ventures, NEA. Develops Adeno-associated viruses(AAV) for gene therapy. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.
What was Affinia Therapeutics's last funding round?
Affinia Therapeutics's latest disclosed round is Series C at $40m (Sep 16, 2025).
Who invested in Affinia Therapeutics?
Affinia Therapeutics has 2 institutional investors on this page, including Google Ventures, NEA.
How does CrackTheDeck cover Affinia Therapeutics?
This startup card lists dated rounds and linked fund profiles so founders can see who is already in the cap table before a pitch.
How is this page compiled?
Round, amount, and investor names on the Affinia Therapeutics card come from dated financings linked to fund profiles in CrackTheDeck. Empty fields mean the figure was not in those records. Updated Aug 2026.